Molecular mechanistic insight of hepatitis B virus mediated hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is a cancer which occurs in liver and severity of this cancer
makes it the sixth most prevalent cancer and second leading cause of death among all …
makes it the sixth most prevalent cancer and second leading cause of death among all …
[HTML][HTML] Hepatocellular carcinoma: Review of disease and tumor biomarkers
JU Kim, MIF Shariff, MME Crossey… - World journal of …, 2016 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a common malignancy and now the second commonest
global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience …
global cause of cancer death. HCC tumorigenesis is relatively silent and patients experience …
Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis
B Hu, X Tian, J Sun, X Meng - International journal of molecular sciences, 2013 - mdpi.com
The clinical value of Serum alpha-fetoprotein (AFP) to detect early hepatocellular carcinoma
(HCC) has been questioned due to its low sensitivity and specificity found in recent years …
(HCC) has been questioned due to its low sensitivity and specificity found in recent years …
Serum protein biomarkers relevant to hepatocellular carcinoma and their detection
E Waidely, ARO Al-Yuobi, AS Bashammakh… - Analyst, 2016 - pubs.rsc.org
Hepatocellular carcinoma (HCC) is one of the most recurrent and lethal cancers worldwide.
The low survival rate of this particular strain of carcinoma is largely due to the late stages at …
The low survival rate of this particular strain of carcinoma is largely due to the late stages at …
Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis
CDM Witjes, SM van Aalten, EW Steyerberg… - Hepatology …, 2013 - Springer
Purpose Early detection of hepatocellular carcinoma (HCC) is essential for improved
prognosis and long-term survival. To date, screening for HCC depends on serological …
prognosis and long-term survival. To date, screening for HCC depends on serological …
[HTML][HTML] Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies
S van Meer, RA de Man, PD Siersema… - World journal of …, 2013 - ncbi.nlm.nih.gov
Primary liver cancer is the sixth most common cancer in the world and the third cause of
cancer-related death. Hepatocellular carcinoma (HCC) represents more than 90% of …
cancer-related death. Hepatocellular carcinoma (HCC) represents more than 90% of …
Abdominal ultrasound and alpha‐foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease
Background Hepatocellular carcinoma (HCC) occurs mostly in people with chronic liver
disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer …
disease and ranks sixth in terms of global instances of cancer, and fourth in terms of cancer …
[HTML][HTML] An overview of biomarkers for the diagnosis of hepatocellular carcinoma
MA El Makarem - Hepatitis monthly, 2012 - ncbi.nlm.nih.gov
Results Serum tumor markers, such as alpha-fetoprotein (AFP) and des-gammacarboxy
prothrombin (DCP) are commonly used for the surveillance, but their roles have been …
prothrombin (DCP) are commonly used for the surveillance, but their roles have been …
[HTML][HTML] Diagnostic value of glypican-3 for hepatocellular carcinomas
Background: Hepatocellular carcinoma (HCC) is a common and dangerous malignancy in
many parts of the world, and especially in Egypt. Early diagnosis is the most important step …
many parts of the world, and especially in Egypt. Early diagnosis is the most important step …
Diagnostic accuracy of SCCA and SCCA‐IgM for hepatocellular carcinoma: A meta‐analysis
CH Liu, A Gil‐Gómez, J Ampuero… - Liver …, 2018 - Wiley Online Library
Abstract Background & Aims Squamous cell carcinoma antigen (SCCA) and its immune
complex (SCCA‐IgM) have been proposed for use in the screening of hepatocellular …
complex (SCCA‐IgM) have been proposed for use in the screening of hepatocellular …